Drug Discovery India 2014 Agenda

Registration

Inauguration

Chairman's Welcome and Inaugural Talk

Renaissance in Pharmacognosy:The Need is Great and the Time is Now
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America

Memento Presentation

Coffee Break and Networking in Exhibition Area

Hall 2- A Novel Approach to Rescue the Neurodegenerative Diseases with the Modified Peptides Derived from Neuron Specific Kinase (Cdk5)
Harish Pant, Senior Investigator, National Institute of Health, United States of America

Hall 1- Novel Heterocyclic Construction Using N-Heterocyclic Carbene Organocatalysis
Akkattu Biju, Senior Scientist, National Chemical Laboratory, India

Hall 2- Chemical Biology Approaches for Target Identification in "Activity Based Proteomic Profiling" Session
Maria Costi, Professor, University of Modena and Reggio Emilia, Italy

Hall 1- DNA-Targeted Anticancer Agents: Molecular Design and their Synthesis
N Shankaraiah, Assistant Professor, NIPER, Hyderabad, India

Hall 1- Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells
Mayur Yergeri, Professor & Prinicipal, Dr Bhanuben Nanavati College of Pharmacy, India

Technology Spotlight:
Hall 2: Using Protein Design Tools to Guide Pharmacophore Generation and Screening
Anand Krishnamurthy, Senior Scientist, Accelrys-BIOVIA

Technology Spotlight:
Hall 1: Drug Discovery & Development: The dilemma of Investing in Software Solutions
K K Bhagchandani, Director, Advanced Chemistry Development Inc

Hall1: Lunch and Networing in the Exhibition Area

Hall 2- Rethinking Drug Discovery: Going-in for Signaling Pathways and Novel Chemical Space to Hunt for Next Generation Functional Small Molecules
Prabhat Arya, Professor and Head, Dr Reddy's Institute of Life Sciences, India

Hall 2: Lunch and Networking in the Exhibition Area

Hall 2- Drugs through Mimicking the Actions of Glycosaminoglycans - Anticoagulants, AntiEmphysema/COPD and Anti-Cancer Stem Cells
Umesh Desai, Professor, Virginia Commonwealth University, United States of America

Hall 1: Dundee, Drug Discovery Unit: Novel Targets and Small Molecule Inhibitors
Ian Gilbert, Head of Chemistry, University of Dundee, United Kingdom

Technology Spotlight:
Hall 2: Maximising Value and Success with Automation
Lesley Schultz, Product Manager, Agilent Technologies

Hall 2-Special Lecture: Protein Ubiquitination Enzymes as Novel Cancer Therapeutic Targets
Amit Banerjee, Professor, Wayne State University , United States of America

Hall 1: Coffee Break and Networking in Exhibition Area

Hall 1- Open-Source Chemoinformatics for virtual screening in Drug Discovery
Muthukumarasamy Karthikeyan, Principal Scientist, National Chemical Laboratory, India

Hall 2- Advances in Developing Tankyrase Selective Inhibitors
Stefan Krauss, Director, University Of Oslo, Norway

Hall 1- Pharmacophore Modeling and Molecular Docking Based Thriving Protocol for Target Identification
Vijay Masand, Assistant Professor, Vidya Bharti College, India

Hall 2- Molecular Methods that Enable Targeted Therapeutics and Precision Medicine
Manohar Furtado, Founder and President, Biology For Global Good Consulting Llc, United States of America

End of First Day of Conference

FREE WORKSHOP: RNA Silencing in Drug Discovery- Challenges and Strategies

Hall 2- Plenary Talk: Bioprocessing of Human Pluripotent Stem Cells using CompacT SelecT Cell Culture Automation
Yacine Laabi, Research Group Leader, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, France

Hall 1- Special Lecture: Moving from Single Drug to Formulation Discovery
Bhushan Patwardhan, Professor & Director- ISHS, University of Pune, India

Hall 2- Stem Cell Based Chip Platforms In Drug Discovery
Subadra Dravida, Founder CEO, Tran-Scell Biologics Pvt. Ltd., India

Hall 1- Natural Products for Drug Discovery and Development: Inspiration from the “Ancient Wisdom of Mother Nature"
Mukund Chorghade, President & CSO, Chorghade Enterprises, United States of America

Technology Spotlight:
Hall 2: Fluent™ Laboratory Automation Solution for Cell-Based Assays
Roland Durner, Global Head of LSB Distributors, Tecan Trading AG

Hall 1:Coffee Break and Networking in Exhibition Area

Hall 2: Coffee Break and Networking in Exhibition Area

Hall 1- "NMITLI Arthritis Model" (Validating Ayurvedic Drugs for Global Use).
Arvind Chopra, Director and Chief Rheumatologist, Center for Rheumatic Diseases, India

Hall 2- Annotating Biological Activities Of Drugs, Natural Products, And Environmental Toxicants by FACTORIAL™ Pathway Profiling Assays
Sergei Makarov, Chief Executive Officer, Attagene Inc, United States of America

Hall 1- Natural Products as New Sources of Drug and Nutraceutical Discovery
Lal Hingorani, Chairman/ Managing Director, Pharmanza Herbal Pvt. Ltd, India

Hall 2- Cell Based Assays in Clinical Diagnostics: Applications to Neutralizing Antibody Assays, Pharmacogenomics, and Personalized Medicine
John Watson, Director, Promega Corporation, United States of America

Hall 1- Plenary Talk: High-throughput in vivo Vertebrate Screening: an Automation Point of View
Giancarlo Basile, Editor in Chief, Current Research in Drug Discovery, Italy

Hall 2- Optimisation of New Trypanosoma brucei Inhibitors
Raphael Rahmani, Research Fellow, Monash University, Australia

Hall 1- Discovery of Novel Compounds for the Treatment of Drug Resistant and Persistent Tuberculosis
Rajkumar Halder, Scientist E, Translational Health Science and Technology Institute, India

Hall 2- Repositioning of Drugs-Structure-Based Approach towards Finding New Leads as Antileishmanial Agents
Sanjay Batra, Principal Scientist, CSIR Central Drug Research Institute, India

Hall 1- High Content Image- Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Multiple Highly Pathogenic RNA Viruses
Krishna Kota, Scientist, PerkinElmer, United States of America

Hall 2- Special Lecture: Natural Products Repurposing for Cancer Therapy
Petr Bartunek, Group Leader, Academy of Sciences of the Czech Republic, Czech Republic

Technology Spotlight:
Hall 1: Leveraging the Power of High Throughput Screening to Identify a Diastereomeric Salt for Chiral Resolution
David Yamane, Product Marketing Director, Freeslate Inc

Hall 1:Lunch and Networking in the Exhibition Area

Hall 2: Lunch and Networking in Exhibition Area

POSTER EVALUATION

Accelerated and Reliable Lead Discovery: Structure Guided Drug Discovery Ideal for Collaborative Projects
Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery, United States of America

Opportunities for Strategic Research Partnerships in Drug Discovery
Ajith Kamath, Head, Pfizer Inc, India

Crowdsourcing Systems Level Platform for Open Source Drug Discovery
Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit, India

Open Source Drug Discovery for Tuberculosis: Lessons to learn
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

Open Discussion on Open Source Drug Discovery

Coffee Break and Networking in Exhibition Area

Panel Discussion: Drug Discovery- Contract Research Landscape in India 2020

End of the Conference